Video Interview: BC Platforms Making Genomic Data Meaningful
This article was originally published in Scrip
BC Platforms CEO Tero Silvola explains to Mike Ward, global director of content for Informa's pharma insights portfolio, how his company is working to solve the challenge pharma and biotech firms face managing and analyzing complex big data in a systematic, standardized and secure manner to improve R&D productivity, clinical decision making and patient outcomes. Founded in 1997, the Switzerland-based biocomputing company has developed technology that can integrate proprietary and public genomic data with wellbeing and healthcare data. The company already has more than 200 clients from academia and industry and is looking to cement its ambition of becoming the market leader in genome knowledge brokering.